Salivary Gland Tumor Flashcards
What are the major salivary glands
Parotid
Submandibular
Sublingual
Largest salivary gland
Parotid
Main excretory duct of parotid
Stensen’s duct
Secretory duct of submandibular
Wharton’s duct
Produces the most saliva
Submandibular or submaxillary
Mainly secretes only pure serous
Parotid
Secretes both serous and mucous
Submandibular or submaxillary
Mixed but mucous is more than serous
Sublingual gland
Main duct of sublingual
Bartholin’s duct
Smaller ducts of sublingual gland that opens independently aong the sublingual fold
Duct of rivinus
Frequency and malignant % rate
parotid gland
Submandibular
Sublingual
Minoy salivary glands
65 25
10. 40
<1. 90
25. 25
Benign salivary gland tumors
Pleomorphic adenoma (mixed tumor)
Basal cell adenoma
Warthin’s tumor (papillary cystadenoma
Malignant salivary gland tumor
Mucoepidermoid carcinoma
Adenoid cystic carcinoma
Acinic cell carcinoma
Characterized by cytomorphological and architectural diversity with an adimxture of ductal and myoepithelial cells usually embedded in a chondromyxoid or fibrous stromal component
Pleomorphic adenoma
Clinical feature of pleomorphic adenoma
Adult, men = women
Asymptomatic submucosal mass
Palate > upper lip > buccal mucosa > other sites
Encapsulated; variable glandular patterns; epithelial and myoepithelial differentiation, no imtoses
Pleomorphic adenoma
Most common tumor of the major and minor salivary gland (50-70%)
Pleomorphic adenoma
% of occurence rate pleomorphic adenoma in the major salivary gland
85%
% of occurrence rate of pleomorphic adenoma in minor salivary glands
8-7%
Gross feature
Lobulated, enclosed within a connective tissue capsule
Minor glands = poorly defined, poor encapsulation
Pleomorphic adenoma
3 key histological features of pleomorphic adenoma
Ductal
Cellular part (myoepithelial cell)
Stroma
Major or minor plemorphic salivary gland
Filled with more cellular than ductal and stroma
Minor salivary gland
IHC profile for ductal component in pleomorphic adenoma
Cytokeratin 3,6,10,11,16
Keratin 7
Keratin 20 (-)
IHC profiling for the cellular component of pleomorphic adenoma
S-100, calponin, a-SMA, calponin
Essential diagnostic criteria for pleomorphic adenoma
Bilayered ducts, myoepithelial cells, chondromyxoid/fibrous stroma
No malignant cytomorphological features
Treatment and prognosis of pleomorphic adenoma
Complete surgical excision
Recurrences occur secondary to rupture and incomplete excision
Recurrence may induce malignant transformation (3%)
Benign salivary neoplasms of histologic uniformity
C
Basal cell adenoma
Composed of basaloid and luminal cells, often with basement membrane material pattern
What are its 4 patterns
Basal cell adenoma
Solid, tubular, cribriform, membranous
Solitary, painless mass, slow-growing and firm
35-80yo (60 mean age) < male
Basal cell adenoma
Location of basal cell adenoma if its a minor salivary gland in origin
Upper lip
1-2% of all salivary gland adenoma, __% in parotid gland
70%
Feature:
Islands/sheets of isomorphic basaloid cells, show peripheral palisading cells at the periphery appearing cuboidal to low columnar
Solid type of basal cell adenoma
Features:
Thin trabeculae and cords of epithelial cells separated by a delicately vascularized stroma
Trabecular form of basal cell adenoma
Features:
Ductal structures with lining cells of cuboidal type surrounded by single or multiple layers of basaloid cells
Tubular type of basal cell adenoma
Features:
Nodular variablt seized isands of tumor tissue urrounded by hyaline membrane, collagenous
Membranous type of basal cell adenoma
A salivary tumor that is usually misdiagnosed with OKC and why?
Basal cell adenoma
Difference - OKC has stellate reticulum cells
IHC profile of basal cell adenoma
Nuclear B-catenin, LEF-1
Is nuclear B-catenin stain positive in pleomorphic adenoma?
Naur
Essential diagnostic criteria for basal cell carcinoma
Basaloid appearance
Peripheral palisading
Treatment and prognosis for basal cell adenoma
Excision, rarely occurs
Except for membranous type (recur 25%; malignant transformation)
Benign salivary gland tumor composed of oncocytic epithelial cells lining ductial, papillary and cystic structures in a lymphoid stroma
Warthin’s tumor
(Papillary cystadenoma lymphomatosum)
Entrapment of salivary gland elements in lymph nodes
<parotid, bilateral
<male (10:1)
62yo mean age
Warthin tumor
Papillary cystadenoma lymphomatosum
Granular, eosinophilic cytoplasm due to numerous large mitochondria
Oncocytes
Gross feature:
Encapsulated, smooth to lobulated surface and a round outline
Warthin’s tumor
Histologic features:
Columnar eosinophilic cells (oncocytes) bilaminar that overlie lymphoid tissue with germinal centers
Warthin’s tumor
(Papillary cystadenoma lymphomatosum)
Bilaminar layer
Warthin’s tumor
Essential diagnostic criteria for warthin’ tumor
Circumscribed mass with spaces lined with papillary bilayered oncocytic cells; lymphoid stroma
Treatment and prognosis
Surgical excision
Recurrences due to incomplete removal
Malignant transformation is rare
Warthin’s tumor
(Papillary cystadenoma lymphomatosum)
Characterized by mucous, intermediate and epidermoid (squamoid( tumor cells forming cystic and solid growth patterns, usually associated with MAML2 rearrangement
Mucoepidermoid carcinoma
Most common malignancy of salivary gland
Mucoepidermoid carcinoma
Most common salivary malignancy in children
Mucoepidermoid carcinoma
60-90% occurs in the parotid gland
Often resembles extravasation or retention type mucocele
If occurs in the parotid land, facial nerve involvement
Mucoepidermoid carcnoma
2 types of mucoepidermoid
And what type does it has more ducts and mucous cells
Low grade mucoepidermoid
High grade mucoepidermoid
Low grade =more ducts and mucous cells
Low-grade lesions - excellent prognosis >95% five year survival
High-grade lesions - fair prognosis >40% five year survival
Mucoepidermoid carcinoma
Mucous cells, intermediate cells, squamous cells
Cystic spaces and solid areas
PAS staining (+) mucinous areas
Histopathologic features of mucoepidermoid carcinoma
IHC profile of mucoepidermoid carcinoma
P63, P40 (+)
S100, SOX10 (-)
Diagnostic molecular pathology
MAML2 positive rearrangement
Invasive carcinoma composed of eithelial and myoepithelial neoplastic cells arranged in tubular,cribriform and solid patterns associated with basophilic matrix and reducplicated basement membrane material, often associated with MYB, MYBL1 or NFIB rearrangement
Adenoid cystic carcinoma
This lsalivary tumor exists mostly in minor salivary gland
It is a high grade salivary gland maligancy which spreads through perineural spaces
Local recurrence an metastasis; lung > nodes
5year survival rate 70%; 15-year survival 10%
Adenoid cystic carcinoma
23% of al salivary gland carcinoma
Adenoid cystic carcinoma
Adults; palatal mass/ulceration
Cribriform microscopic pattern
Adenoid cystic carcinoma
Infiltrative, slow growing unilobular mass that is firm on palpation
Facial nerve paralysis
Adenoid cystic carcinoma
Hallmark of adenoid cystic carcinoma
Perineural invasion
IHC profile of adenoid cystic carcinoma
CK7 CD117 positive (ductal cells)
P63, p40, calponin, SMA (myoepithelial cells)
Diagnostic molecular pathology of adenoid cystic carcinoma
MYB/MYBL1 rearrangement
Prolonged clinical course, with frequent local recurrences, late onset of metastases and fatal outcome
Treatment/prognosis for adenoid cystic carcinoma
Salivary gland carcinoma exhibiting serous acinar and lacking mucinous differentiation
Bilateral parotid 3%
90-95% parotid
Acinic cell carcinoma
Second most common salivary gland malignancy in children
Acinic cell carcinoma
Slow growing lesion
Pain
High grade tumors may be rapidly growing and fixed to adjacent structures that facial nerve paralysis
Acinic cell carcinoma
Neoplastic cells are heterogeneous with the most comon cell type being the serous acinar cell
Acinic cell carcinoma
Most common cell type of acinic cell carcinoma
Serous acinar cell
Zymogen granules
Acinic cell carcinoma
IHC profile of acinic cell carcinoma
SOX10 and DOG1(+)
P40/p63, S100 (-)
NR4A3 or NR4A2 (+)
% of distant metastasis of acinic cell carcinoma and where
15% DM to LN (10%)